Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty: A Randomized Controlled Trial

Anesthesiology

Volumn 127, Issue 3, 2017, Pages 413-422

  Zufferey, Paul J ^a,b   Lanoiselée, Julien ^a,b   Chapelle, Céline ^a,b   Borisov, Dmitry B ^c   Bien, Jean Yves ^b   Lambert, Pierre ^b   Philippot, Rémi ^b,d,e   Molliex, Serge ^b   Delavenne, Xavier ^a,b,d   Barbe, Nicolas ^b   Gavory, Julie ^b   Passot, Sylvie ^b   Burnol, Laetitia ^b   Seve, Stéphanie ^b  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

^d UNIVERSITÉ DE LYON   (France)

^e Univ Lyon University Jean Monnet Saint Etienne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

AGED; ARTICLE; AVASCULAR NECROSIS; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HIP DYSPLASIA; HIP OSTEOARTHRITIS; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; PARALLEL DESIGN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; BLOOD LOSS, SURGICAL; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PERIOPERATIVE PERIOD; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, INTRAVENOUS; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 85022225320     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001787     Document Type: Article

References (29)

1. Ker K, Edwards P, Perel P, Shakur H, Roberts I: Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis. BMJ 2012; 344:e3054
2. Mannucci PM: Hemostatic drugs. N Engl J Med 1998; 339:245-53
3. Eriksson BI, Hultman E, Martinell S, Eriksson E, Tengborn L, Risberg B: Regional fibrinolysis following total hip replacement. Thromb Res 1991; 62:441-7
4. Blanié A, Bellamy L, Rhayem Y, Flaujac C, Samama CM, Fontenay M, Rosencher N: Duration of postoperative fibrinolysis after total hip or knee replacement: A laboratory followup study. Thromb Res 2013; 131:e6-e11
5. Imai N, Dohmae Y, Suda K, Miyasaka D, Ito T, Endo N: Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 2012; 27:1838-43
6. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A: Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347:289-92
7. Pilbrant A, Schannong M, Vessman J: Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 1981; 20:65-72
8. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S: Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? ANESTHESIOLOGY 2006; 105:1034-46
9. Friedrich JO, Adhikari NK, Beyene J: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study. BMC Med Res Methodol 2008; 8:32
10. Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A: Much ado about nothing: A comparison of the performance of metaanalytical methods with rare events. Stat Med 2007; 26:53-77
11. Borisov DB, Yudin SV, Krylov OV, Markov BB, Istomina NA: Reduction of perioperative blood loss during endoprosthetic replacement of large joints. Gen Reanimatol 2011; 7:34-7
12. Borisov DB, Yudin SV, Lebedev LA, Vardanashvili VK, Istomina NA: Choice of a tranexamic acid dose regimen during endoprosthetic replacement of joints. Messenger Anesthesiol Resusc 2011; 8:41-4
13. Hourlier H, Fennema P: Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: A randomised clinical trial. Hip Int 2014; 24:63-8
14. Barrachina B, Lopez-Picado A, Remon M, Fondarella A, Iriarte I, Bastida R, Rodríguez-Gascón A, Achaerandio MA, Iturricastillo MC, Aizpuru F, Valero CA, Tobalina R, Hernanz R: Tranexamic acid compared with placebo for reducing total blood loss in hip replacement surgery: A randomized clinical trial. Anesth Analg 2016; 122:986-95
15. Sun Q, Yu X, Wu J, Ge W, Cai M, Li S: Efficacy of a single dose and an additional dose of tranexamic acid in reduction of blood loss in total knee arthroplasty. J Arthroplasty 2017; 32:2108-12
16. Xie J, Ma J, Yao H, Yue C, Pei F: Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: A randomized clinical trial. J Arthroplasty 2016; 31:2458-64
17. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S: Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 2001; 83:702-5
18. Hourlier H, Reina N, Fennema P: Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: A randomised clinical trial. Arch Orthop Trauma Surg 2015; 135:465-71
19. Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO: The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45:605-10
20. Katsumata S, Nagashima M, Kato K, Tachihara A, Wauke K, Saito S, Jin E, Kawanami O, Ogawa R, Yoshino S: Changes in coagulation-fibrinolysis marker and neutrophil elastase following the use of tourniquet during total knee arthroplasty and the influence of neutrophil elastase on thromboembolism. Acta Anaesthesiol Scand 2005; 49:510-6
21. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J: Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. ANESTHESIOLOGY 2002; 97:390-9
22. Xie J, Ma J, Yue C, Kang P, Pei F: Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: A randomised clinical trial. Hip Int 2016; 26:36-42
23. Yi Z, Bin S, Jing Y, Zongke Z, Pengde K, Fuxing P: Tranexamic acid administration in primary total hip arthroplasty: A randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 2016; 98:983-91
24. Lopez-Picado A, Albinarrate A, Barrachina B: Determination of perioperative blood loss: Accuracy or approximation? Anesth Analg 2017; 125:280-6
25. Spahn DR: Anemia and patient blood management in hip and knee surgery: A systematic review of the literature. ANESTHESIOLOGY 2010; 113:482-95
26. Blood Transfusion. London, National Institute for Health and Care Excellence (UK), 2015. Available at: http://www.ncbi. nlm.nih.gov/books/NBK327570/. Accessed September 20, 2016
27. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL: Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. ANESTHESIOLOGY 2002; 96:1140-6
28. Pedersen AB, Mehnert F, Sorensen HT, Emmeluth C, Overgaard S, Johnsen SP: The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: A 15-year retrospective cohort study of routine clinical practice. Bone Joint J 2014; 96-B:479-85
29. Rosenfeld BA, Beattie C, Christopherson R, Norris EJ, Frank SM, Breslow MJ, Rock P, Parker SD, Gottlieb SO, Perler BA: The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis: Perioperative Ischemia Randomized Anesthesia Trial Study Group. ANESTHESIOLOGY 1993; 79:435-43